Cargando…

Predicting the treatment response of certolizumab for individual adult patients with rheumatoid arthritis: protocol for an individual participant data meta-analysis

BACKGROUND: A model that can predict treatment response for a patient with specific baseline characteristics would help decision-making in personalized medicine. The aim of the study is to develop such a model in the treatment of rheumatoid arthritis (RA) patients who receive certolizumab (CTZ) plus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yan, Chalkou, Konstantina, Yamada, Ryo, Funada, Satoshi, Salanti, Georgia, Furukawa, Toshi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477831/ https://www.ncbi.nlm.nih.gov/pubmed/32532307 http://dx.doi.org/10.1186/s13643-020-01401-x

Ejemplares similares

Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment: An Individual Participant Data Meta-Analysis
por: Luo, Yan, et al.
Publicado: (2023)

Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol
por: Tomlinson, Anneka, et al.
Publicado: (2020)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Khan, Abdul, et al.
Publicado: (2011)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Decision Curve Analysis for Personalized Treatment Choice between Multiple Options
por: Chalkou, Konstantina, et al.
Publicado: (2022)

A two‐stage prediction model for heterogeneous effects of treatments
por: Chalkou, Konstantina, et al.
Publicado: (2021)

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
por: Furst, D E, et al.
Publicado: (2015)

Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
por: Hynnekleiv, Leif, et al.
Publicado: (2020)

Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
por: Hannech, Emna, et al.
Publicado: (2021)

Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients
por: Santos-Moreno, Pedro, et al.
Publicado: (2021)

Predictors of the effects of treatment for shoulder pain: protocol of an individual participant data meta-analysis
por: van der Windt, Danielle A., et al.
Publicado: (2019)

Exercise therapy for chronic low back pain: protocol for an individual participant data meta-analysis
por: Hayden, Jill A, et al.
Publicado: (2012)

Prefilled certolizumab pegol (Cimzia(®)) syringes for self-use in the treatment of rheumatoid arthritis
por: Rosa, J, et al.
Publicado: (2010)

Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis
por: Soriano, Enrique R, et al.
Publicado: (2018)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
por: Schneider-Thoma, Johannes, et al.
Publicado: (2021)

Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis
por: Furukawa, Toshi A, et al.
Publicado: (2016)

Acceptance and commitment therapy for chronic pain: protocol of a systematic review and individual participant data meta-analysis
por: Lin, Jiaxi, et al.
Publicado: (2019)

Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis
por: Sakai, Hiroyuki, et al.
Publicado: (2017)

Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study
por: Funada, Satoshi, et al.
Publicado: (2021)

Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol
por: Stewart, Lesley A., et al.
Publicado: (2017)

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety
por: Mease, Philip J.
Publicado: (2011)

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
por: Bykerk, V P, et al.
Publicado: (2015)

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis
por: Carron, Philippe, et al.
Publicado: (2016)

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021)

Rational and design of an individual participant data meta-analysis of spinal manipulative therapy for chronic low back pain—a protocol
por: de Zoete, A., et al.
Publicado: (2017)

Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure
por: Pufulete, Maria, et al.
Publicado: (2014)

Epidemiology of rheumatoid arthritis in sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Essouma, Mickael, et al.
Publicado: (2020)

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity
por: Pope, Janet, et al.
Publicado: (2015)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
por: Mendonça, José Alexandre, et al.
Publicado: (2019)

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
por: Kang, Young Mo, et al.
Publicado: (2018)

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
por: Fleischmann, Roy, et al.
Publicado: (2017)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
por: Paul, Stéphane, et al.
Publicado: (2020)

Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature
por: Koda, Keigo, et al.
Publicado: (2020)

Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
por: Bassi, Andrea, et al.
Publicado: (2023)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
por: Ostinelli, Edoardo G, et al.
Publicado: (2019)

PROTOCOL: Mass deworming for soil‐transmitted helminths and schistosomiasis among pregnant women: a systematic review and individual participant data meta‐analysis
por: Salam, Rehana A, et al.
Publicado: (2018)

Differences in the Oral Microbiome in Patients With Early Rheumatoid Arthritis and Individuals at Risk of Rheumatoid Arthritis Compared to Healthy Individuals
por: Kroese, Johanna M., et al.
Publicado: (2021)

Postural control of the trunk in individuals with and without low back pain during unstable sitting: A protocol for a systematic review with an individual participant data meta-analysis
por: Alshehri, Mansour Abdullah, et al.
Publicado: (2022)

Guided or self-guided internet-based cognitive–behavioural therapy (iCBT) for depression? Study protocol of an individual participant data network meta-analysis
por: Karyotaki, Eirini, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ounto4h2tgl727ijphibmc423k